Cargando…
Hybrid Argon Plasma Coagulation for Treatment of Gastric Intestinal Metaplasia
Hybrid argon plasma coagulation (HybridAPC® [HAPC]) is an evolution of the standard argon plasma coagulation (APC) technology, where the application of APC is preceded by high-pressure needleless submucosal injection. APC is indicated for the ablation of benign and dysplastic mucosal lesions, such a...
Autores principales: | Estifan, Elias, Cavanagh, Yana, Grossman, Matthew A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182158/ https://www.ncbi.nlm.nih.gov/pubmed/32337147 http://dx.doi.org/10.7759/cureus.7427 |
Ejemplares similares
-
Predicting Gastric Intestinal Metaplasia in a High-Risk Population
por: Akpoigbe, Kesiena, et al.
Publicado: (2022) -
The Impact of Argon Plasma Coagulation in the Treatment of a Solitary Rectal Ulcer Syndrome Revealed by Massive Hemorrhage
por: Nadi, Anass, et al.
Publicado: (2022) -
Development of hyperplastic polyps following argon plasma coagulation of gastric antral vascular ectasia
por: Shah, Nihar, et al.
Publicado: (2015) -
Incidence of Pneumoperitoneum After Gastrostomy Tube Removal
por: Mahmoud, Anas, et al.
Publicado: (2023) -
Pancreatic Solid Pseudopapillary Tumor Associated with Elevated DHEA and Testosterone
por: Estifan, Elias, et al.
Publicado: (2019)